Blujepa Tablet, Film Coated
Product Images NDC 0173-0922

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Blujepa (NDC 0173-0922). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gepotidacin Mesylate Dihydrate Chemical Structure (Blujepa Spl Graphic 01)

Chemical structure of gepotidacin, the active ingredient in Blujepa 750 mg oral tablet, as depicted with molecular bonds and chemical groups including hydrate and methanesulfonic acid components.*

FDA Label Image

Blujepa Tablet 20 Count Label (Blujepa Spl Graphic 02)

Label for Blujepa (gepotidacin) tablets, 750 mg strength, film-coated oral tablets. The label indicates 20 tablets per package. It includes storage instructions, safety seal warning, and manufacturer information for GlaxoSmithKline LLC, made in Belgium. The label also features the NDC 0173-0922-45 and a QR code for additional product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.